Ultimately, further investigation into both CCL4 and CCL3L1’s roles in mediating tumor immune infiltration following NACT exposure is warranted, as it could potentially lead to original approaches to combat the immunosuppressive ovarian TIME. The gene discussed is CCL3L3; the disease is neoplasm.